Total Funding
88
70
Total FundingDebt Financing raised
Growth Score
5 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
72653
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
About the Company
LynxDx is a privately held pre-revenue diagnostic company headquartered in Ann Arbor, Michigan, with research facilities just a few miles away from the University of Michigan Health System. LynxDx currently is focused on commercializing diagnostic tools, including a diagnostic qPCR assay for COVID-19 and a urine assay to aid in the diagnosis of
prostate cancer (MyProstateScore). LynxDx currently operates a CLIA-licensed high-complexity molecular diagnostics laboratory that serves to commercially provide its diagnostic assays.
